Dr. Sophie Dix from MQ introduces MQ as the first major charity that raises funds to invest in scientific research for mental health. They have been set up to tackle the major challenges in mental health so that we can increase understanding, improve treatments and bring hope of prevention to patients.
Dr. Sophie Dix is the Director of Research at MQ. Prior to that, she spent 14 years at Eli Lilly based in Surrey. Her work included efforts to understand the neural circuitry underpinning behavioural endophenotypes associated with Psychiatric and Neurodegenerative disease. Dr. Dix has had a leadership role in a major EU-funded IMI (Innovative Medicines Initiative) project on biomarkers for Alzheimer’s Disease (PharmaCog). She also sits on the UK government scientific advisory committee on the use of animals in scientific research.